Opus Genetics Inc. (IRD)
Market Open
3 Mar, 15:06
NASDAQ (CM) NASDAQ (CM) Primary $
4. 29
-0.04
-1.04%
$
286.89M Market Cap
- P/E Ratio
- Div Yield
146,434 Volume
- Eps
$ 4.33
Previous Close Day Range
4.16 4.49
Year Range
0.65 4.49
Want to track IRD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
IRD earnings report is expected in 27 days (30 Mar 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
IRD Earnings Reports FAQ
What is the earnings per share (EPS) for IRD?
EPS data for IRD is currently not available, as Opus Genetics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Opus Genetics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-30, based on the IRD's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Opus Genetics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for IRD at this time, as Opus Genetics Inc has no recent EPS data to calculate it.
